22P HER2-low vs HER2-zero metastatic breast carcinoma: A clinical and genomic descriptive analysisRodrigo Sánchez-Bayona, Eva Ciruelos, M. Luisa Marín et al.|Annals of Oncology|2021Cited by 13
62P A multi-center real-world study of the efficacy and safety of PARP inhibitors in patients with ovarian cancer in SpainRodrigo Sánchez-Bayona, Ainhoa Madariaga, C. Maximiano Alonso et al.|ESMO Open|2024Cited by 0